San Francisco, April 26 (IANS) Former US President Donald Trump has decided not to join Twitter despite Tesla CEO Elon Musk buying it, saying "Twitter has become very boring".
Trump said that he will not return to Twitter and will instead use his own 'TRUTH Social' as the only social media platform.
"I am not going on Twitter, I am going to stay on TRUTH. I hope Elon makes improvements to it and he is a good man, but I am going to be staying on TRUTH," Trump was quoted as saying in a Fox News report late on Monday.
Trump said he will begin "TRUTHing" over the next week.
The former President announcement came moments after Musk won a takeover bid to take Twitter private for $44 billion at $54.20 a share.
"Twitter's become very boring. They've gotten rid of a lot of good voices on Twitter, a lot of their conservative voices," he said.
Trump was permanently suspended from Twitter, Facebook, Instagram, and Snapchat following the Capitol Hill riot on January 6, 2021.
"This is a platform for my voice. TRUTH is a platform for my voice and for my supporters," Trump said.
"But I want everybody to come over to TRUTH -- conservatives, liberals, whatever."
He did not comment if he was in contact with Musk.
"I hope that even my worst critics remain on Twitter, because that is what free speech means," Musk had tweeted.
It is not clear, however, whether any of the passports under development will be accepted broadly around the world, and the result could be confusion among travellers and disappointment for the travel industry.
As details emerge, many members of the Asian American community see the Georgia killings as a haunting reminder of harassment and assaults that have been occurring from coast to coast.
Norway, Iceland, Bulgaria, Thailand, and Congo soon followed suit. On Saturday, Norwegian authorities reported that four people under age 50 who had gotten the AstraZeneca vaccine had an unusually low number of blood platelets.
In a statement, the U.N. health agency said “the ample data from large clinical trials” shows the J&J vaccine is effective in adult populations. The emergency use listing comes a day after the European Medicines Agency recommended the shot be given the green light across the 27-country European Union.
Denmark's Health Authority said its decision was “based on a precautionary principle” and that one person who developed a blood clot after vaccination had died.
